Core Laboratories Inc.
CLB
$10.44
-$0.16-1.51%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.19M | 22.11M | 19.16M | 21.47M | 17.70M |
| Total Receivables | 127.95M | 130.99M | 127.36M | 132.38M | 130.73M |
| Inventory | 59.77M | 59.03M | 59.40M | 65.49M | 69.90M |
| Prepaid Expenses | 10.52M | 10.31M | 10.18M | 9.72M | 9.86M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.25M | 6.34M | 10.52M | 6.17M | 5.34M |
| Total Current Assets | 237.68M | 228.77M | 226.61M | 235.23M | 233.53M |
|
|
|||||
| Total Current Assets | 237.68M | 228.77M | 226.61M | 235.23M | 233.53M |
| Net Property, Plant & Equipment | 153.04M | 155.43M | 153.55M | 154.26M | 154.20M |
| Long-term Investments | 100.00M | 99.45M | 99.45M | 99.45M | 99.45M |
| Goodwill | 100.00M | 99.45M | 99.45M | 99.45M | 99.45M |
| Total Other Intangibles | 6.17M | 6.28M | 6.40M | 6.55M | 6.67M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 105.23M | 101.59M | 99.32M | 104.99M | 103.95M |
| Total Assets | 602.11M | 591.52M | 590.41M | 600.47M | 597.80M |
|
|
|||||
| Total Accounts Payable | 41.70M | 38.50M | 34.55M | 33.63M | 36.86M |
| Total Accrued Expenses | 28.94M | 28.63M | 30.01M | 28.08M | 26.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.51M | 11.65M | 10.69M | 11.44M | 11.05M |
| Total Finance Division Other Current Liabilities | 22.62M | 24.95M | 22.34M | 21.80M | 22.76M |
| Total Other Current Liabilities | 22.62M | 24.95M | 22.34M | 21.80M | 22.76M |
| Total Current Liabilities | 104.77M | 103.73M | 97.59M | 94.94M | 97.60M |
|
|
|||||
| Total Current Liabilities | 104.77M | 103.73M | 97.59M | 94.94M | 97.60M |
| Long-Term Debt | 124.61M | 124.37M | 126.11M | 139.87M | 147.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 42.42M | 43.98M | 43.34M | 43.73M | 42.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 63.00M | 60.09M | 65.63M | 65.51M | 64.27M |
| Total Liabilities | 334.81M | 332.16M | 332.67M | 344.05M | 352.11M |
|
|
|||||
| Common Stock & APIC | 113.23M | 114.04M | 110.02M | 113.08M | 113.95M |
| Retained Earnings | 159.82M | 149.66M | 150.28M | 143.35M | 132.07M |
| Treasury Stock & Other | -11.77M | -10.31M | -8.31M | -5.68M | -5.74M |
| Total Common Equity | 261.28M | 253.39M | 251.99M | 250.74M | 240.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 261.28M | 253.39M | 251.99M | 250.74M | 240.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 6.02M | 5.97M | 5.75M | 5.68M | 5.42M |
| Total Equity | 267.30M | 259.36M | 257.74M | 256.42M | 245.69M |
|
|
|||||